ERMARD
Endoplasmic reticulum membrane-associated RNA degradation protein
Also known as: C6orf70, dJ266L20.3, EMARD_HUMAN, FLJ11152
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T6L9
- Gene
- ERMARD
- Ensembl
- ENSG00000130023
- Chromosome
- 6
- Canonical length
- 678 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The protein encoded by this gene contains 2 transmembrane domains near the C-terminus and is localized in the endoplasmic reticulum. Knockout of this gene in developing rat brain showed that it may be involved in neuronal migration. Mutations in this gene are associated with periventricular nodular heterotopia-6 (PVNH6). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]
Canonical amino-acid sequenceUniProt
678 residues, UniProt reviewed canonical sequence.
>Q5T6L9|ERMARD
1 MEVLIGDPIT TCLSPSVYDI ICNLGFQLRE NCDINSIVTQ NGEVCWKTIT DCVSYTESEQ
61 GLDYWGSVRL LGPVCEAVHS HFLSLTKGQF EIRYAPWFQW TSFPELFPEI FDALESLQSP
121 AISLSLMKLT SCLERALGDV FLLIGKECPF LLRDLLSSEE LAQVFSQSVM NVLKVFVGSP
181 CGLNLRNVLW HGFASPEEIP PKYCSMMILL TAGLGQLLKS YLQNTKLTLA HRSFISLTNL
241 EDLIVFPDVT YEVLSVLEEV MMKSAFILKI MLPYWEVALV KFKSHRFADC AILLLTQLET
301 GLRNVFATLN RCPKRLLTAE STALYTTFDQ ILAKHLNDGK INQLPLFLGE PAMEFLWDFL
361 NHQEGPRIRD HLSHGEINLH EFSKETTNQL LAFSLVLLLR FVDDCLLSVF KEKSAVELLI
421 SLAEGYSSRC HPVFQLKKQV LSCEESIRVW ALLPFPEELT RQAVRLEDNS ETNACHSLIT
481 KMTDELYHHM PENRCVLKDL DRLPTETWPQ LLRELCSTPV PTLFCPRIVL EVLVVLRSIS
541 EQCRRVSSQV TVASELRHRQ WVERTLRSRQ RQNYLRMWSS IRLLSPVLSL ILLLIALELV
601 NIHAVCGKNA HEYQQYLKFV KSILQYTENL VAYTSYEKNK WNETINLTHT ALLKMWTFSE
661 KKQMLIHLAK KSTSKVLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERMARD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- testis: 21 nTPM
- epididymis: 19 nTPM
- liver: 18 nTPM
- skin: 18 nTPM
- ovary: 17 nTPM
- spleen: 17 nTPM
Single-cell type
- oocytes: 170 nCPM
- late spermatids: 65 nCPM
- late primary spermatocytes: 52 nCPM
- podocytes: 46 nCPM
- early spermatids: 41 nCPM
- ependymal cells: 40 nCPM
Immune cell
- non-classical monocyte: 9.8 nTPM
- intermediate monocyte: 7.9 nTPM
- T-reg: 7.7 nTPM
- memory CD4 T-cell: 6 nTPM
- naive B-cell: 6 nTPM
- memory CD8 T-cell: 5.9 nTPM
Brain region
- white matter: 19 nTPM
- medulla oblongata: 16 nTPM
- basal ganglia: 15 nTPM
- spinal cord: 14 nTPM
- pons: 14 nTPM
- thalamus: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ERMARD.
Disease | AllUniProt
Conditions ERMARD is implicated in, by any mechanism.
- Periventricular nodular heterotopia 6 (PVNH6) MIM:615544
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 376 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Periventricular nodular heterotopia 6
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.32
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Endoplasmic reticulum membrane-associated RNA degradation protein, N-terminal
- Endoplasmic reticulum membrane-associated RNA degradation protein
- Domain of unknown function (DUF4209)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERMARD as an antibody target. Whether an autoantibody or antibody against ERMARD could matter depends on whether native ERMARD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERMARD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ERMARD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...